Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Cash from Investing Activities

Arena Pharmaceutical Cash from Investing Activities Chart (ARNA)

Arena Pharmaceutical annual/quarterly Cash from Investing Activities from 2000 to 2018.
  • Arena Pharmaceutical Cash from Investing Activities for the quarter ending September 09, 2018 was $38m a 97.92% increase of 37m year over year
  • Arena Pharmaceutical Cash from Investing Activities for the last 12 months ending September 09, 2018 was $-51m a -120.86% increase of 62m year over year
  • Arena Pharmaceutical Annual Cash from Investing Activities for 2017 was $-112m a 99.33% decrease of -112m from 2016
  • Arena Pharmaceutical Annual Cash from Investing Activities for 2016 was $-1m a -986.80% increase of 7m from 2015
  • Arena Pharmaceutical Annual Cash from Investing Activities for 2015 was $-8m a 601.83% decrease of -49m from 2014
Other Cash Flow Metrics:
  • Arena Pharmaceutical Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceutical Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Cash from Investing Activities Data

09/2018$38m
06/2018$22m
03/2018$2m
09/2017$1m
06/2017$0m
03/2017$0m
09/2016$0m
06/2016$0m
03/2016$0m
12/2015$0m

Annual ARNA Cash from Investing Activities Data

2017$-112m
2016$-1m
2015$-8m
2014$41m
2013$-9m
2012$-2m
2011$-1m
2010$16m
2009$11m
2008$-68m